| Literature DB >> 30116402 |
Qian Zhang1, Ruiling Luan2, Huixiang Li1, Yanan Liu1, Pan Liu1, Liying Wang1, Danna Li1, Mengdi Wang1, Qiang Zou3, Hongwei Liu4, Keiichi Matsuzaki5, Feng Zhao1.
Abstract
Ambuic acid is an organic acid isolated from the solid culture of Pestalotiopsis neglecta, which is an endophytic fungus that widely exists in many species of plants. Ambuic acid has been reported to exert antimicrobial activity against Gram-positive bacterium. The aim of the present study was to investigate the inhibitory effect of ambuic acid on lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophages. The results demonstrated that ambuic acid significantly suppressed the overproduction of nitric oxide (NO) and prostaglandin E2 (PGE2) in a dose-dependent manner. Furthermore, ambuic acid also inhibited the release of the proinflammatory cytokine interleukin-6 (IL-6) however, no inhibition of the release of tumor necrosis factor-α (TNF-α) was observed. Further investigations indicated that ambuic acid downregulated the LPS-induced high expression of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) proteins, as well as inhibited the enzymatic activity of iNOS and COX-2. In addition, ambuic acid suppressed the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK 1/2) and c-Jun N-terminal kinase (JNK) induced by LPS. However, ambuic acid did not inhibit the phosphorylation of p38 mitogen-activated protein kinase (MAPK), the degradation of IκB-α protein or the nuclear translocation of nuclear transcription factor-κB (NF-κB) p65 subunit. These results suggested that ambuic acid may exert anti-inflammatory action by blocking the activation of the ERK/JNK MAPK signaling pathway, without the involvement of the p38 MAPK or NF-κB signaling pathways.Entities:
Keywords: Anti-inflammatory activity; Pestalotiopsis neglecta; ambuic acid; cyclooxygenase-2; inducible nitric oxide synthase; mitogen-activated protein kinase
Year: 2018 PMID: 30116402 PMCID: PMC6090306 DOI: 10.3892/etm.2018.6294
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447